Teva Pharmaceutical Industries Ltd.

Evan Lippman - Initial Statement of Beneficial Ownership of Securities false


�� "�	2 380
TEVA- PHARMACEUTICAL INDUSTRIES LTD
Corporation no: 520013954	10205
- - -


	Israel Securities Authority			Tel Aviv Stock Exchange		C002 ( Public )		Reported via MAGNA:	07/04/2025
	www.isa.gov.il			www.tase.co.il				Reference:	2025-02-025910	Time of broadcast: 23:01 23:01

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000


	The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report onEvan Lippman - Initial Statement of Beneficial Ownership of Securities

Form_3_-_Evan_Lippman_-_isa.pdf



References of previous documents relating to this matter(the reference does not constitute incorporation by reference):


- - -
Stock Exchange/Market: NYSE	Date of revision of form structure: 06/08/2024
Address: Dvora Hanevi'a 124 , Tel Aviv 6944020 , Tel: 03-9148262 , Fax: 03-9267519
E-mail address: [email protected]

Previous names of reporting entity:

Name of the Signatory: Bergwerk Dov Position of Signatory in the reporting corporation: Vice President & General Counsel Name of Employer Company:
Address: Dvora Hanevi'a 124 , Tel Aviv 6944020 Telephone: 03-9267756 Facsimile: 03-9267429 E-mail: [email protected] 1

AI Terminal